BrianJohn AndrGillMD(He/Him)
Neurosurgery • New York, NYBrain & Spinal Tumor
Assistant Professor of Neurological Surgery
Overview of Dr. Gill
Dr. Brian Gill is a neurosurgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 3 years. He is one of 132 doctors at New York-Presbyterian Hospital and one of 56 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurosurgery. He has more than 20 publications and over 450 citings.
Office
710 West 168th Street
New York, NY 10032
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Neurosurgical Oncology, 2021 - 2022
New York Presbyterian Hospital (Columbia Campus)Residency, Neurological Surgery, 2014 - 2021
Columbia University Vagelos College of Physicians and SurgeonsClass of 2014
Certifications & Licensure
NY State Medical License 2021 - 2026
CT State Medical License 2022 - 2025
NJ State Medical License 2022 - 2025
CO State Medical License 2022 - 2023
Clinical Trials
- A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma Start of enrollment: 2023 Mar 20
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 13 citationsSynaptic hyperexcitability of cytomegalic pyramidal neurons contributes to epileptogenesis in tuberous sclerosis complex.Xiaoping Wu, Alexander A Sosunov, Wudu Lado, Jia Jie Teoh, Ahrom Ham
Cell Reports. 2022-07-19 - 193 citationsMRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastomaBrian J A Gill, David J. Pisapia, Hani Malone, Hannah E. Goldstein, Liang Lei
Proceedings of the National Academy of Sciences of the United States of America. 2014-08-26 - 26 citationsChronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial.Eleonora F Spinazzi, Michael G Argenziano, Pavan S Upadhyayula, Matei A Banu, Justin A Neira
The Lancet. Oncology. 2022-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
